Tempest Therapeutics, Inc. (TPST) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
TPST currently has 14.8M outstanding shares. with significant dilution risk as 159M authorized shares could dilute existing holders by 1072.5%. The company has significantly diluted shareholders by 353.74% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 14, 2026 |
10-Q filing | 14.8M shares outstanding |
15M | 160M |
| Mar 30, 2026 |
10-K filing | 14.3M shares outstanding |
14M | 150M |
| Mar 30, 2026 |
S-3 filing: This is an S-3 filing for the offer and resale of 8,268,495 shares of common stock by selling stockholders. |
4.4M | 170M |
| Dec 09, 2025 |
S-1 filing: This prospectus relates to the offer and resale from time to time of up to an aggregate 1,172,414 shares of common stock issuable upon the exercise of warrants by the selling stockholder. |
4.4M | 160M |
| Nov 05, 2025 |
10-Q filing | 4.4M shares outstanding |
4.4M | 160M |
| Aug 11, 2025 |
10-Q filing | 4.4M shares outstanding |
4.4M | 160M |
| May 13, 2025 |
10-Q filing | 3.4M shares outstanding |
3.4M | 160M |
| Mar 27, 2025 |
10-K filing | 45.5M shares outstanding |
45M | 120M |
| Jan 24, 2025 |
S-3/A filing: This S-3/A filing registers an indeterminate number of shares of common stock and preferred stock, an indeterminate principal amount of debt securities, an indeterminate number of warrants to purchase common stock, preferred stock and/or debt securities, an indeterminate amount of units and such indeterminate amount of rights to purchase common stock, preferred stock and/or debt securities to be sold by the registrant from time to time at unspecified prices which shall have an aggregate initial offering price not to exceed $300,000,000. |
44M | 120M |
| Nov 12, 2024 |
10-Q filing | 43.6M shares outstanding |
44M | 130M |
| Aug 08, 2024 |
10-Q filing | 25.2M shares outstanding |
25M | 150M |
| Jul 19, 2024 |
S-3 filing: The company is filing an S-3 to offer up to $300,000,000 of any combination of common stock, preferred stock, and debt securities. |
21M | 150M |
| May 09, 2024 |
10-Q filing | 22.2M shares outstanding |
22M | 0 |
| Mar 19, 2024 |
10-K filing | 22.2M shares outstanding |
22M | 0 |
| Nov 08, 2023 |
10-Q filing | 19.2M shares outstanding |
19M | 0 |
| Aug 10, 2023 |
10-Q filing | 14.1M shares outstanding |
14M | 4.9M |
| May 10, 2023 |
10-Q filing | 11.6M shares outstanding |
12M | 7.5M |
| Mar 22, 2023 |
10-K filing | 11.5M shares outstanding |
12M | 7.5M |
| Nov 08, 2022 |
10-Q filing | 10.5M shares outstanding |
11M | 8.5M |
| Aug 15, 2022 |
10-Q filing | 10.4M shares outstanding |
10M | 8.6M |
| May 16, 2022 |
S-3 filing: This S-3 filing registers shares of common stock held by selling stockholders, who will sell them from time to time. The company will not receive any proceeds from these sales. |
10M | 8.7M |
| May 13, 2022 |
10-Q filing | 10.3M shares outstanding |
10M | 8.7M |
| Mar 29, 2022 |
10-K filing | 7.2M shares outstanding |
7.2M | 12M |
| Nov 10, 2021 |
10-Q filing | 6.7M shares outstanding |
6.7M | 12M |
| Aug 12, 2021 |
10-Q filing | 6.7M shares outstanding |
6.7M | 12M |
| Jul 16, 2021 |
S-3 filing: The filing is an S-3 registration statement for a shelf offering of up to $250,000,000 of common stock, preferred stock, debt securities, rights to purchase common stock, preferred stock, debt securities or units. |
19M | 0 |
| May 13, 2021 |
10-Q filing | 19.0M shares outstanding |
19M | 0 |
| Mar 29, 2021 |
10-K filing | 19.0M shares outstanding |
19M | 0 |
| Nov 09, 2020 |
10-Q filing | 19.0M shares outstanding |
19M | 0 |
| Aug 10, 2020 |
10-Q filing | 19.0M shares outstanding |
19M | 0 |
| May 08, 2020 |
10-Q filing | 13.5M shares outstanding |
13M | 0 |
| Mar 11, 2020 |
10-K filing | 18.3M shares outstanding |
18M | 0 |